Several studies have demonstrated that the mechanisms involved in tumor-suppressing effects of IRF-8 include the downregulation of Bcl-2 expression, as well as the upregulation of c-Myc inhibitor, blimp1, and METs (17). The gene discussed is IRF8; the disease is neoplasm.